Patents by Inventor Martin J. Fennell

Martin J. Fennell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11571147
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: February 7, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Publication number: 20220361756
    Abstract: Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver is configured for communicating with a remote transmitter unit coupled with a glucose sensor. The glucose sensor generates data signals associated with a glucose level. The receiver unit includes a processor, a display, and a memory for storing instructions which, when executed by the processor: access a transmitter key associated with the remote transmitter unit; transmit a command to the remote transmitter unit after verifying the transmitter key; receive communication packets from the remote transmitter unit including a first data segment with data signals indicative of the glucose level and a second data segment with information corresponding to a remaining life of the remote transmitter unit; estimate a remaining life of the remote transmitter unit; process the data signals; and output the estimated remaining life and the processed data signals for display.
    Type: Application
    Filed: July 27, 2022
    Publication date: November 17, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20220359074
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20220330856
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Application
    Filed: November 22, 2021
    Publication date: October 20, 2022
    Inventors: Martin J. Fennell, Jean-Pierre Cole, Theodore John Kunich, Udo Hoss, Benjamin Jay Feldman, Zenghe Liu
  • Publication number: 20220283042
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Application
    Filed: October 19, 2021
    Publication date: September 8, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Publication number: 20220181022
    Abstract: Methods and devices and systems include generating analyte data based on signals from an analyte sensor transcutaneously positioned in contact with interstitial fluid under a skin layer of a user and to generate signals corresponding to an analyte level of a target analyte. The analyte data corresponds to the analyte level of the target analyte over a wear period. Methods include storing the analyte data over the wear period. Methods include determining one or more indications based on the analyte data. Methods include determining a reimbursement insurance code based at least in part on stored sensor information associated with the analyte sensor. Methods include communicating at least a portion of the analyte data and the reimbursement insurance code to an electronic record associated with the user and stored by a remote electronic medical record system. Methods include providing the one or more indications on a user interface unit.
    Type: Application
    Filed: February 22, 2022
    Publication date: June 9, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: 11276492
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: March 15, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: 11264133
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: March 1, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: 11213226
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: January 4, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Martin J. Fennell, Jean-Pierre Cole, Theodore John Kunich, Udo Hoss, Benjamin Jay Feldman, Zenghe Liu
  • Publication number: 20210321950
    Abstract: Methods and devices for determining a measurement time period, receiving a plurality of signals associated with a monitored analyte level during the determined measurement time period from an analyte sensor, modulating the received plurality of signals to generate a data stream over the measurement time period, and accumulating the generated data stream to determine an analyte signal corresponding to the monitored analyte level associated with the measurement time period are provided. Systems and kits are also described.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Martin J. Fennell
  • Patent number: 11150145
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: October 19, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Patent number: 11045147
    Abstract: Methods and devices for determining a measurement time period, receiving a plurality of signals associated with a monitored analyte level during the determined measurement time period from an analyte sensor, modulating the received plurality of signals to generate a data stream over the measurement time period, and accumulating the generated data stream to determine an analyte signal corresponding to the monitored analyte level associated with the measurement time period are provided. Systems and kits are also described.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: June 29, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Martin J. Fennell
  • Publication number: 20210169327
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Application
    Filed: February 19, 2021
    Publication date: June 10, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20210151182
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 20, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: 10952611
    Abstract: Methods and systems for providing data communication in medical systems are disclosed.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: March 23, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Martin J. Fennell, Lei He, Mark Kent Sloan
  • Publication number: 20210000396
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Application
    Filed: September 11, 2020
    Publication date: January 7, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Patent number: D955599
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: June 21, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D957642
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D957643
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: July 12, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Christopher Allen Thomas, Udo Hoss, Martin J. Fennell, Lei He, Michael Love, Phillip Yee
  • Patent number: D962446
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: August 30, 2022
    Assignee: ABBOTT DIABETES CARE, INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub